SLC (4167.TWO) monthly revenue, September 2026
SLC reported revenue of NT$0.10bn for September 2026, down 11.2% from the previous month and up 33.7% from a year earlier. Year-to-date revenue was NT$0.84bn, down 4.9% year on year. It ranked 39 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.10 | -11.2 | 33.7 |